
Therapeutic hypothermia applied to patients with cardiogenic shock complicating acute myocardial infarction did not provide additional benefit, a new recent study from Circulation suggested.
Researchers for the Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction (SHOCK-COOL) trial enrolled 40 patients with cardiogenic shock following acute myocardial infarction who were undergoing percutaneous coronary intervention and randomized them 1:1 to either mild therapeutic hypothermia for 24 hours or usual care. The primary study endpoint was cardiac power index at 24 hours.
https://twitter.com/grahamnichol/statuses/1038121902449942528